This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaegi, E.
Right arrow Articles by Task Force on Alternative Therapies of the Canadian Breast Cancer Research, Institute.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaegi, E.
Right arrow Articles by Task Force on Alternative Therapies of the Canadian Breast Cancer Research, Institute.
Related Collections
Right arrow Unconventional Therapies for Cancer Series

Canadian Medical Association Journal, Vol 158, Issue 7 897-902, Copyright © 1998 by Canadian Medical Association

Review * Synthèse

Unconventional therapies for cancer: 1. Essiac

E. Kaegi and Institute. Task Force on Alternative Therapies of the Canadian Breast Cancer Research

Physicians and patients have been frustrated by the lack of reliable information on unconventional therapies. To help fill this gap in the area of breast cancer therapy, the Canadian Breast Cancer Research Initiative formed a task force to advise it on how best to promote research into unconventional therapies. As part of the work of the task force, a review of the available literature was carried out for each of the following products: Essiac, green tea, Iscador, hydrazine sulfate, vitamins A, C and E, and 714-X. The first article in this series on unconventional therapies for cancer describes the methodology used to obtain and evaluate the information and provides a summary of the findings on Essiac. Subsequent articles will cover the other products. For most of the products reviewed, there has been some indication of possible benefit but no definitive evidence. Innovative and collaborative research needed to meet the information needs of growing numbers of patients and their physicians is now being sponsored by the Canadian Breast Cancer Research Initiative. Open communication between patients and physicians is also necessary for the maintenance of an appropriate therapeutic partnership and for the identification and control of side effects. The Ontario Division of the Canadian Cancer Society, a partner in the Canadian Breast Cancer Research Initiative, supported the preparation of a patient-information piece on unconventional therapies to accompany the series. This item will assist patients who are considering such therapies and will promote open communication between patients and their physicians.


This article has been cited by other articles:


Home page
 CMAJHome page
M. Begin and E. Kaegi
Unconventional therapies and cancer
Can. Med. Assoc. J., September 1, 1999; 161(6): 686 - 687.
[Full Text] [PDF]